Recurrence of Cutaneous T-Cell Lymphoma Post Viral Vector COVID-19 Vaccination

    October 2021 in “ Journal of the European Academy of Dermatology and Venereology ”
    Evdoxia Panou, Vasiliki Nikolaou, Leonidas Marinos … Alexander Stratigos
    Studysummary This report describes two cases where a viral vector COVID-19 vaccine was associated with the recurrence of cutaneous lymphoma conditions that had been in remission.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on onlinelibrary.wiley.com →
    Discuss this study in the Community →